Status:

COMPLETED

Why Still in Neurosurgical Ward After Tumor Craniotomy?

Lead Sponsor:

Rigshospitalet, Denmark

Conditions:

Surgery--Complications

Brain Tumor

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this prospective observational study is to identify the specific reasons that prolong a hospital stay after elective tumor craniotomy. Optimal postoperative in-hospital stay is considered t...

Detailed Description

The concept of fast-track surgery and later enhanced recovery after surgery (ERAS) was first imputed in 1990s. Since then, ERAS protocols have been successfully adopted in many surgical fields, often ...

Eligibility Criteria

Inclusion

  • Patients scheduled for elective brain tumor craniotomy

Exclusion

  • Stereotactic biopsy, pituitary surgery and laser interstitial thermal therapy (LITT)

Key Trial Info

Start Date :

June 12 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 15 2023

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT05288088

Start Date

June 12 2022

End Date

November 15 2023

Last Update

November 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Neuroanesthesiology, Rigshospitalet

Copenhagen, Denmark

Why Still in Neurosurgical Ward After Tumor Craniotomy? | DecenTrialz